93 related articles for article (PubMed ID: 18793877)
1. Overcoming pubic arch interference with free-hand needle placement in men undergoing prostate brachytherapy.
Gibbons EP; Smith RP; Beriwal S; Krishna K; Benoit RM
Brachytherapy; 2009; 8(1):74-8. PubMed ID: 18793877
[TBL] [Abstract][Full Text] [Related]
2. Prostate brachytherapy with oblique needles to treat large glands and overcome pubic arch interference.
Ryu B; Bax J; Edirisinge C; Lewis C; Chen J; D'Souza D; Fenster A; Wong E
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1463-72. PubMed ID: 22270172
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric outcomes in prostate brachytherapy: is downsizing the prostate with androgen deprivation necessary?
Gibbons EP; Jacobs BL; Smith RP; Beriwal S; Krishna K; Benoit RM
Brachytherapy; 2009; 8(3):304-8. PubMed ID: 19217354
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
5. Use of TRUS to predict pubic arch interference of prostate brachytherapy.
Wallner K; Ellis W; Russell K; Cavanagh W; Blasko J
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):583-5. PubMed ID: 10078641
[TBL] [Abstract][Full Text] [Related]
6. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
7. Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants.
Tincher SA; Kim RY; Ezekiel MP; Zinsli T; Fiveash JB; Raben DA; Bueschen AJ; Urban DA
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):361-3. PubMed ID: 10802360
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods.
van den Bosch MR; Lips IM; Lagerburg V; van Vulpen M; Lagendijk JJ; Moerland MA
Radiother Oncol; 2008 Jan; 86(1):120-5. PubMed ID: 18037520
[TBL] [Abstract][Full Text] [Related]
9. Intra-operative pubic arch interference during prostate seed brachytherapy in patients with CT-based pubic arch interference of < or =1cm.
Sejpal SV; Sathiaseelan V; Helenowski IB; Kozlowski JM; Carter MF; Nadler RB; Dalton DP; McVary KT; Lin WW; Garnett JE; Kalapurakal JA
Radiother Oncol; 2009 May; 91(2):249-54. PubMed ID: 19272664
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
Potters L; Calugaru E; Jassal A; Presser J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
[TBL] [Abstract][Full Text] [Related]
11. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
Shirvani SM; Kudchadker RJ; Bruno TL; Likhacheva A; Swanson DA; Frank SJ
Brachytherapy; 2011; 10(4):269-74. PubMed ID: 21296031
[TBL] [Abstract][Full Text] [Related]
12. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry and cancer control after low-dose-rate prostate brachytherapy.
Robert Lee W; Deguzman AF; McMullen KP; McCullough DL
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):52-9. PubMed ID: 15629593
[TBL] [Abstract][Full Text] [Related]
14. Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
Smith RP; Beriwal S; Komanduri K; Gibbons E; Benoit R
Brachytherapy; 2008; 7(3):237-41. PubMed ID: 18599357
[TBL] [Abstract][Full Text] [Related]
15. Pubic arch detection in transrectal ultrasound guided prostate cancer therapy.
Pathak SD; Grimm PD; Chalana V; Kim Y
IEEE Trans Med Imaging; 1998 Oct; 17(5):762-71. PubMed ID: 9874300
[TBL] [Abstract][Full Text] [Related]
16. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
17. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Pro-Qura Database: rectal dose, implant quality, and brachytherapist's experience.
Loiselle CR; Waheed M; Sylvester J; Allen ZA; Grimm PD; Eulau S; Butler WM; Merrick GS
Brachytherapy; 2009; 8(1):34-9. PubMed ID: 19056321
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy for large prostate volumes (> or =50cc)-Uncompromised dosimetric coverage and acceptable toxicity.
Monroe AT; Faricy PO; Jennings SB; Biggers RD; Gibbs GL; Peddada AV
Brachytherapy; 2008; 7(1):7-11. PubMed ID: 18299109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
